These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 17054550)
1. Tumour size as a predictor of axillary node metastases in patients with breast cancer. Laura S; Coombs NJ; Ung O; Boyages J ANZ J Surg; 2006 Nov; 76(11):1002-6. PubMed ID: 17054550 [TBL] [Abstract][Full Text] [Related]
2. [Management of the axilla in breast cancer: evidences and unresolved issues]. Fodor J; Polgár C; Péley G; Németh G Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099 [TBL] [Abstract][Full Text] [Related]
3. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer. Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207 [TBL] [Abstract][Full Text] [Related]
4. A decision tool for predicting sentinel node accuracy from breast tumor size and grade. Coombs N; Chen W; Taylor R; Boyages J Breast J; 2007; 13(6):593-8. PubMed ID: 17983402 [TBL] [Abstract][Full Text] [Related]
5. Predictors of axillary lymph node metastases in women with early breast cancer in Singapore. Tan LG; Tan YY; Heng D; Chan MY Singapore Med J; 2005 Dec; 46(12):693-7. PubMed ID: 16308642 [TBL] [Abstract][Full Text] [Related]
6. Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer. Hatoum HA; Jamali FR; El-Saghir NS; Musallam KM; Seoud M; Dimassi H; Abbas J; Khalife M; Boulos FI; Tawil AN; Geara FB; Salem Z; Shamseddine AA; Al-Feghali K; Shamseddine AI Ann Surg Oncol; 2009 Dec; 16(12):3388-95. PubMed ID: 19655200 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer. Pierga JY; Mouret E; Diéras V; Laurence V; Beuzeboc P; Dorval T; Palangié T; Jouve M; Vincent-Salomon A; Scholl S; Extra JM; Asselain B; Pouillart P Br J Cancer; 2000 Dec; 83(11):1480-7. PubMed ID: 11076657 [TBL] [Abstract][Full Text] [Related]
8. The role of axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases. Gipponi M; Canavese G; Lionetto R; Catturich A; Vecchio C; Sapino A; Friedman D; Cafiero F Eur J Surg Oncol; 2006 Mar; 32(2):143-7. PubMed ID: 16300921 [TBL] [Abstract][Full Text] [Related]
9. Axillary lymph node metastases in patients with small carcinomas of the breast: is accurate prediction possible? Anan K; Mitsuyama S; Tamae K; Nishihara K; Iwashita T; Abe Y; Ihara T; Toyoshima S Eur J Surg; 2000 Aug; 166(8):610-5. PubMed ID: 11003428 [TBL] [Abstract][Full Text] [Related]
10. Factors that predict the burden of axillary disease in breast cancer patients with a positive sentinel node. Beriwal S; Soran A; Kocer B; Wilson JW; Ahrendt GM; Johnson R Am J Clin Oncol; 2008 Feb; 31(1):34-8. PubMed ID: 18376225 [TBL] [Abstract][Full Text] [Related]
11. Axillary lymph node dissection in pT1 breast cancer: a retrospective analysis of 315 patients and review of the literature. Witt A; Obwegeser R; Auerbach L; Tempfer C; Yavuz D; Kubista E Wien Klin Wochenschr; 2002 Jun; 114(10-11):387-90. PubMed ID: 12708092 [TBL] [Abstract][Full Text] [Related]
12. Prediction of lymph node status by analysis of prognostic factors and possible indications for elective axillary dissection in T1 breast cancers. Guarnieri A; Neri A; Correale PP; Lottini M; Testa M; Mariani F; Tucci E; Megha T; Cintorino M; Carli A Eur J Surg; 2001 Apr; 167(4):255-9. PubMed ID: 11354316 [TBL] [Abstract][Full Text] [Related]
13. The significance of one positive axillary node. Kuijt GP; van de Poll-Franse LV; Roumen RM; van Beek MW; Voogd AC Eur J Surg Oncol; 2006 Mar; 32(2):139-42. PubMed ID: 16412602 [TBL] [Abstract][Full Text] [Related]
14. Cellular dyscohesion in fine-needle aspiration of breast carcinoma. Prognostic indicator for axillary lymph node metastases? Schiller AB; Tadros TS; Birdsong GG; Grossl NA Am J Clin Pathol; 2001 Feb; 115(2):219-23. PubMed ID: 11211610 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of residual breast disease and axillary node involvement for patients who had primary induction chemotherapy for advanced breast cancer. Escobar PF; Patrick RJ; Rybicki LA; Hicks D; Weng DE; Crowe JP Ann Surg Oncol; 2006 Jun; 13(6):783-7. PubMed ID: 16604475 [TBL] [Abstract][Full Text] [Related]
16. Accuracy of fine-needle aspiration cytology of axillary lymph nodes in breast cancer patients: a study of 115 cases with cytologic-histologic correlation. Alkuwari E; Auger M Cancer; 2008 Apr; 114(2):89-93. PubMed ID: 18286535 [TBL] [Abstract][Full Text] [Related]
17. [Axillary skip metastases in breast cancer]. Sun JY; Ning LS Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):352-5. PubMed ID: 18953834 [TBL] [Abstract][Full Text] [Related]
18. CD44 expression and axillary lymph node metastasis in infiltrating ductal carcinoma of the breast. Looi LM; Cheah PL; Zhao W; Ng MH; Yip CH Malays J Pathol; 2006 Dec; 28(2):83-6. PubMed ID: 18376796 [TBL] [Abstract][Full Text] [Related]
19. Intramammary lymph nodes and breast cancer: a marker for disease severity, or just another lymph node? Guth AA; Mercado C; Roses DF; Hiotis K; Skinner K; Diflo T; Cangiarella J Am J Surg; 2006 Oct; 192(4):502-5. PubMed ID: 16978960 [TBL] [Abstract][Full Text] [Related]
20. The likelihood of additional nodal disease following a positive sentinel lymph node biopsy in breast cancer patients: validation of a nomogram. Cripe MH; Beran LC; Liang WC; Sickle-Santanello BJ Am J Surg; 2006 Oct; 192(4):484-7. PubMed ID: 16978955 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]